Get started
Author

Tricia M. Wright

Observed names: T M Wright, T. M. Wright, T.M. Wright, Tricia M Wright, Tricia Wright, Wright, Tricia M.
OpenAlex ID: A5087211196
Polysensory Interactions along Lateral Temporal Regions Evoked by Audiovisual Speech
2003 · T. M. Wright · Cerebral Cortex · 277
Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma
2009 · T M Wright, A R Brannon, et al. · Oncogene · 116
The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer
2019 · Kimberly J. Cocce, Jeff S. Jasper, et al. · Cell Reports · 76
Delineation of a FOXA1/ERα/AGR2 Regulatory Loop That Is Dysregulated in Endocrine Therapy–Resistant Breast Cancer
2014 · Tricia M. Wright, Suzanne E. Wardell, et al. · Molecular Cancer Research · 47
Molecularly targeted therapy in renal cell carcinoma
2005 · W Kimryn Rathmell, Tricia M Wright, et al. · Expert Review of Anticancer Therapy · 34
Receptor Tyrosine Kinase-like Orphan Receptor 2 (Ror2) Expression Creates a Poised State of Wnt Signaling in Renal Cancer
2013 · Neal R. Rasmussen, Tricia M. Wright, et al. · Journal of Biological Chemistry · 28
Identification of Ror2 as a Hypoxia-inducible Factor Target in von Hippel-Lindau-associated Renal Cell Carcinoma
2010 · Tricia M. Wright, W. Kimryn Rathmell · Journal of Biological Chemistry · 27
Distinct LIN-10 Domains Are Required for Its Neuronal Function, Its Epithelial Function, and Its Synaptic Localization
2005 · Doreen R. Glodowski, Tricia Wright, et al. · Molecular Biology of the Cell · 27
Expression of Ror2 Mediates Invasive Phenotypes in Renal Cell Carcinoma
2014 · Neal R. Rasmussen, Zufan Debebe, et al. · PLoS ONE · 24
PDF
Supplementary Materials and Methods, Figure Legends from Delineation of a FOXA1/ERα/AGR2 Regulatory Loop That Is Dysregulated in Endocrine Therapy–Resistant Breast Cancer
2023 · Tricia M. Wright, Suzanne E. Wardell, et al.
PDF
Supplementary Figure 3 from Delineation of a FOXA1/ERα/AGR2 Regulatory Loop That Is Dysregulated in Endocrine Therapy–Resistant Breast Cancer
2023 · Tricia M. Wright, Suzanne E. Wardell, et al.
Supplementary Figure 1 from Delineation of a FOXA1/ERα/AGR2 Regulatory Loop That Is Dysregulated in Endocrine Therapy–Resistant Breast Cancer
2023 · Tricia M. Wright, Suzanne E. Wardell, et al.
PDF
Supplementary Figure 4 from Delineation of a FOXA1/ERα/AGR2 Regulatory Loop That Is Dysregulated in Endocrine Therapy–Resistant Breast Cancer
2023 · Tricia M. Wright, Suzanne E. Wardell, et al.
Supplementary Figure 7 from Delineation of a FOXA1/ERα/AGR2 Regulatory Loop That Is Dysregulated in Endocrine Therapy–Resistant Breast Cancer
2023 · Tricia M. Wright, Suzanne E. Wardell, et al.
Supplementary Figure 6 from Delineation of a FOXA1/ERα/AGR2 Regulatory Loop That Is Dysregulated in Endocrine Therapy–Resistant Breast Cancer
2023 · Tricia M. Wright, Suzanne E. Wardell, et al.
PDF
Supplementary Figure 2 from Delineation of a FOXA1/ERα/AGR2 Regulatory Loop That Is Dysregulated in Endocrine Therapy–Resistant Breast Cancer
2023 · Tricia M. Wright, Suzanne E. Wardell, et al.
Supplementary Figure 5 from Delineation of a FOXA1/ERα/AGR2 Regulatory Loop That Is Dysregulated in Endocrine Therapy–Resistant Breast Cancer
2023 · Tricia M. Wright, Suzanne E. Wardell, et al.
Data from Delineation of a FOXA1/ERα/AGR2 Regulatory Loop That Is Dysregulated in Endocrine Therapy–Resistant Breast Cancer
2023 · Tricia M. Wright, Suzanne E. Wardell, et al.
Data from Delineation of a FOXA1/ERα/AGR2 Regulatory Loop That Is Dysregulated in Endocrine Therapy–Resistant Breast Cancer
2023 · Tricia M. Wright, Suzanne E. Wardell, et al.
Supplementary Figure 2 from Delineation of a FOXA1/ERα/AGR2 Regulatory Loop That Is Dysregulated in Endocrine Therapy–Resistant Breast Cancer
2023 · Tricia M. Wright, Suzanne E. Wardell, et al.
PDF
Supplementary Figure 6 from Delineation of a FOXA1/ERα/AGR2 Regulatory Loop That Is Dysregulated in Endocrine Therapy–Resistant Breast Cancer
2023 · Tricia M. Wright, Suzanne E. Wardell, et al.
Supplementary Figure 5 from Delineation of a FOXA1/ERα/AGR2 Regulatory Loop That Is Dysregulated in Endocrine Therapy–Resistant Breast Cancer
2023 · Tricia M. Wright, Suzanne E. Wardell, et al.
PDF
Supplementary Figure 1 from Delineation of a FOXA1/ERα/AGR2 Regulatory Loop That Is Dysregulated in Endocrine Therapy–Resistant Breast Cancer
2023 · Tricia M. Wright, Suzanne E. Wardell, et al.
Supplementary Figure 7 from Delineation of a FOXA1/ERα/AGR2 Regulatory Loop That Is Dysregulated in Endocrine Therapy–Resistant Breast Cancer
2023 · Tricia M. Wright, Suzanne E. Wardell, et al.
PDF
Supplementary Materials and Methods, Figure Legends from Delineation of a FOXA1/ERα/AGR2 Regulatory Loop That Is Dysregulated in Endocrine Therapy–Resistant Breast Cancer
2023 · Tricia M. Wright, Suzanne E. Wardell, et al.
Works count: 31
Citation count: 656
H-index: 9
I10-index: 9
Year
Topic
Type